|
Volumn 51, Issue 2, 2002, Pages 91-98
|
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy
|
Author keywords
BCG treatment; Bladder cancer; Chemokine; MCP 1; RANTES
|
Indexed keywords
BCG VACCINE;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PHYTOHEMAGGLUTININ;
RANTES;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BCG VACCINATION;
BLADDER CARCINOMA;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
FEMALE;
HUMAN;
HUMAN TISSUE;
INCUBATION TIME;
INFLAMMATION;
MALE;
MEMORY CELL;
MONOCYTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SECRETION;
BCG VACCINE;
CHEMOKINE CCL2;
HUMANS;
IMMUNOTHERAPY;
MONOCYTES;
RANTES;
RNA, MESSENGER;
URINARY BLADDER NEOPLASMS;
|
EID: 0036118371
PISSN: 03407004
EISSN: None
Source Type: Journal
DOI: 10.1007/s00262-001-0254-2 Document Type: Article |
Times cited : (27)
|
References (36)
|